DarioHealth to Participate in Upcoming Investor Conferences
On November 5, 2021, DarioHealth Corp. (Nasdaq: DRIO) announced its participation in two upcoming investor conferences.
Rhea-AI Summary
On November 5, 2021, DarioHealth Corp. (Nasdaq: DRIO) announced its participation in two upcoming investor conferences. The first is the Credit Suisse 30th Annual Healthcare Conference on November 9, featuring a fireside chat with CEO Erez Raphael at 9:40 am EST. The second event is the Craig-Hallum 12th Annual Alpha Select Conference on November 16. Interested parties can access the live and archived webcasts of these events on DarioHealth's investor website. DarioHealth is at the forefront of digital therapeutics, offering comprehensive solutions for chronic condition management.
Details
News Market Reaction – DRIO
The recorded move for DRIO in the trading session of this news was +0.11%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Nov. 5, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate at the following conferences:
Credit Suisse 30th Annual Healthcare Conference
Format: Investor one-on-one meetings
Date: Tuesday, November 9, 2021
Live Fireside Chat with Erez Raphael, Chief Executive Officer of DarioHealth: 9:40 am EST
Craig-Hallum 12th Annual Alpha Select Conference
Format: Investor one-on-one meetings
Date: Tuesday, November 16, 2021
Interested parties can access the live and archived webcast of the Credit Suisse presentation on the Events and Presentations section of Dario's Investors website, https://dariohealth.investorroom.com/.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform.
Dario's next-generation, AI-powered, digital therapeutic platform supports more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes.
Dario's unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results.
The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and utilizes a performance-based approach to improve its users' health.
On the path to better health, Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit https://dariohealth.com.
DarioHealth Corporate Contact:
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220
Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390
Media Contact:
Josephine Galatioto
Josephine.galatioto@russopartnersllc.com
+1-212-845-4262
Logo - http://mma.prnewswire.com/media/544126/DarioHealth_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/dariohealth-to-participate-in-upcoming-investor-conferences-301417532.html
SOURCE DarioHealth Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.